Michael Haude

Showing 1-20 of 66 articles

Coronary interventions

EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of the European Society of Cardiology.

Van Belle E, Teles R, Pyxaras S, Kalpak O, Johnson T, Barbash I, De Luca G, Kostov J, Parma R, Vincent F, Brugaletta S, Debry N, Toth G, Ghazzal Z, Deharo P, Milasinovic D, Kaspar K, Saia F, Mauri Ferre J, Kammler J, Muir D, O'Connor S, Mehilli J, Thiele H, Weilenmann D, Witt N, Joshi F, Kharbanda R, Piroth Z, Wojakowski W, Geppert A, Di Gioia G, Pires-Morais G, Petronio A, Estevez-Loureiro R, Ruzsa Z, Kefer J, Kunadian V, Van Mieghem N, Windecker S, Baumbach A, Haude M, Dudek D

May 16, 2021 | 10.4244/EIJ-D-18-00448

Coronary interventions

Impact of clinical and haemodynamic factors on coronary flow reserve and invasive coronary flow capacity in non-obstructed coronary arteries: a patient-level pooled analysis of the DEBATE and ILIAS studies

Stegehuis V, Wijntjens G, Bax M, Meuwissen M, Chamuleau S, Voskuil M, Koch K, Di Mario C, Vrints C, Haude M, Boersma E, Serruys P, Piek J, van der Hoef T

April 2, 2021 | 10.4244/EIJ-D-19-00774

Interventions for valvular disease

Computed tomography angiography imaging of the Carillon device topography after unsuccessful treatment of functional mitral regurgitation

Rottländer D, Gödde M, Degen H, Haude M

March 19, 2021 | 10.4244/EIJ-D-20-00332

Coronary interventions

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

Onuma Y, Chevalier B, Ono M, Cequier A, Dudek D, Haude M, Carrié D, Sabaté M, Windecker S, Rapoza R, West N, Reith S, de Sousa Almeida M, Campo G, Iniguez-Romo A, Serruys P

December 4, 2020 | 10.4244/EIJ-D-20-00024

Coronary interventions

Preclinical investigation of neoatherosclerosis in magnesium-based bioresorbable scaffolds versus thick-strut drug-eluting stents

Nicol P, Bulin A, Castellanos M, Stöger M, Obermeier S, Lewerich J, Lenz T, Hoppmann P, Baumgartner C, Fischer J, Steiger K, Haude M, Joner M

December 4, 2020 | 10.4244/EIJ-D-19-00747

Reply: Cardiac CT prior to percutaneous coronary sinus-based mitral annuloplasty with the Carillon device

Rottländer D, Gödde M, Degen H, Haude M

November 20, 2020 | 10.4244/EIJ-D-20-00621R

Coronary interventions

Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial

Takahashi K, Chichareon P, Modolo R, Kogame N, Chang C, Tomaniak M, Moschovitis A, Curzen N, Haude M, Jung W, Holmvang L, Garg S, Tijssen J, Wykrzykowska J, de Winter R, Hamm C, Steg P, Stoll H, Onuma Y, Valgimigli M, Vranckx P, Windecker S, Serruys P

October 23, 2020 | 10.4244/EIJ-D-19-00498

Coronary interventions

Safety and performance of the second-generation drug-eluting absorbable metal scaffold (DREAMS 2G) in patients with de novo coronary lesions: three-year clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial

Haude M, Ince H, Toelg R, Lemos P, von Birgelen C, Christiansen E, Wijns W, Neumann F, Eeckhout E, Garcia-Garcia H, Waksman R

February 7, 2020 | 10.4244/EIJ-D-18-01000

Coronary interventions

Twelve-month outcomes of 400 patients treated with a resorbable metal scaffold: insights from the BIOSOLVE-IV registry

Verheye S, Wlodarczak A, Montorsi P, Bennett J, Torzewski J, Haude M, Vrolix M, Buck T, Aminian A, van der Schaaf R, Nuruddin A, Lee M

February 7, 2020 | 10.4244/EIJ-D-18-01058

Coronary interventions

BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months

Saito S, Toelg R, Witzenbichler B, Haude M, Masotti M, Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T

December 6, 2019 | 10.4244/EIJ-D-18-01214

Evolving paradigms in valvular heart disease: where should guidelines move?

Baumbach A, Dudek D, Baumgartner H, Windecker S, Haude M

November 15, 2019 | 10.4244/EIJ-D-19-00818

Interventions for valvular disease

Coronary sinus to mitral valve annulus topography and response to the percutaneous coronary sinus-based mitral valve contour system

Rottländer D, Schneider T, Degen H, Laufenberg M, Chatrou M, Haude M

November 15, 2019 | 10.4244/EIJ-D-19-00054

Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) – Nice, France, 20-21 June 2018

Barbato E, Mauri Ferre J, Byrne R, Roffi M, Fitzsimons D, Toth G, Capodanno D, Mehilli J, Petronio A, Chieffo A, Vardas P, Naber C, Dudek D, Haude M, Baumbach A

April 16, 2019 | 10.4244/EIJV14I17A297

Will ORBITA change my practice? ORBITA trial: Objective Randomised Blinded Investigation with optimal medical Therapy of Angioplasty in stable angina

Schueler R, Al-Lamee R, Mahfoud F, Capodanno D, Asnag M, Haude M

October 19, 2018 | 10.4244/EIJY18M09_2

Stents and scaffolds

Preclinical evaluation of degradation kinetics and elemental mapping of first- and second-generation bioresorbable magnesium scaffolds

Joner M, Ruppelt P, Zumstein P, Lapointe-Corriveau C, Leclerc G, Bulin A, Castellanos M, Wittchow E, Haude M, Waksman R

October 12, 2018 | 10.4244/EIJ-D-17-00708

Welcome to PCR London Valves 2018: 10th Anniversary Edition

Barbanti M, Prendergast B, Haude M, Piazza N, Windecker S, Baumbach A, Tamburino C

September 7, 2018 | 10.4244/EIJV14SABA1

Other

Evaluating the importance of sham-controlled trials in the investigation of medical devices in interventional cardiology

Byrne R, Capodanno D, Mahfoud F, Fajadet J, Windecker S, Jüni P, Baumbach A, Wijns W, Haude M

August 24, 2018 | 10.4244/EIJ-D-18-00481

EAPCI Presidential “criss-cross”

Baumbach A, Haude M

May 20, 2018 | 10.4244/EIJV14I1A7

May in Paris! Join us! EuroPCR 2018

Haude M

April 20, 2018 | 10.4244/EIJV13I17A326

Answering the challenges of the New Year – the EAPCI in 2018

Haude M

January 19, 2018 | 10.4244/EIJV13I13A243

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.